Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 433787011000036111 | Bordetella pertussis, acellular pertussis toxoid vaccine 20 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 20 microgram + Bordetella pertussis, fimbriae types 2 and 3 vaccine 5 microgram + Bordetella pertussis, acellular pertactin vaccine 3 microgram + diphtheria toxoid vaccine 30 units + tetanus toxoid vaccine 40 units + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 433790011000036111 | Bordetella pertussis, acellular pertactin vaccine 3 microgram + Bordetella pertussis, acellular pertussis toxoid vaccine 20 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 20 microgram + Bordetella pertussis, fimbriae types 2 and 3 vaccine 5 microgram + diphtheria toxoid vaccine 30 international units + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units + tetanus toxoid vaccine 40 international units injection, 1 x 0.5 mL vial (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bordetella pertussis, acellular pertussis toxoid vaccine 20 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 20 microgram + Bordetella pertussis, fimbriae types 2 and 3 vaccine 5 microgram + Bordetella pertussis, acellular pertactin vaccine 3 microgram + diphtheria toxoid vaccine 30 units + tetanus toxoid vaccine 40 units + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL vial | Is a | medicinal product pack | false | Inferred relationship | Some | ||
| Bordetella pertussis, acellular pertussis toxoid vaccine 20 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 20 microgram + Bordetella pertussis, fimbriae types 2 and 3 vaccine 5 microgram + Bordetella pertussis, acellular pertactin vaccine 3 microgram + diphtheria toxoid vaccine 30 units + tetanus toxoid vaccine 40 units + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL vial | has MPUU | Bordetella pertussis, acellular pertussis toxoid vaccine 20 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 20 microgram + Bordetella pertussis, fimbriae types 2 and 3 vaccine 5 microgram + Bordetella pertussis, acellular pertactin vaccine 3 microgram + diphtheria toxoid vaccine 30 units + tetanus toxoid vaccine 40 units + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL vial | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Quadracel injection suspension, 0.5 mL vial | Is a | False | Bordetella pertussis, acellular pertussis toxoid vaccine 20 microgram + Bordetella pertussis, filamentous haemagglutinin vaccine 20 microgram + Bordetella pertussis, fimbriae types 2 and 3 vaccine 5 microgram + Bordetella pertussis, acellular pertactin vaccine 3 microgram + diphtheria toxoid vaccine 30 units + tetanus toxoid vaccine 40 units + poliomyelitis virus type 1 (Mahoney) inactivated vaccine 40 D antigen units + poliomyelitis virus type 2 (MEF1) inactivated vaccine 8 D antigen units + poliomyelitis virus type 3 (Saukett) inactivated vaccine 32 D antigen units injection, 0.5 mL vial | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR